Olga V Stepanenko
Overview
Explore the profile of Olga V Stepanenko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
337
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sulatsky M, Stepanenko O, Stepanenko O, Mikhailova E, Sulatskaya A
Cell Death Discov
. 2025 Feb;
11(1):61.
PMID: 39955315
Amyloid fibrils cause organ and tissue dysfunction in numerous severe diseases. Despite the prevalence and severity of amyloidoses, there is still no effective and safe anti-amyloid therapy. This study investigates...
2.
Sulatsky M, Stepanenko O, Stepanenko O, Mikhailova E, Sulatskaya A
Int J Biol Macromol
. 2025 Feb;
:140971.
PMID: 39952498
Amyloid fibrils, linked to severe pathologies such as neurodegenerative diseases, pose a significant challenge to modern medicine. Lysosomal proteases, particularly cathepsins, have attracted attention for their potential role in modulating...
3.
Stepanenko O, Sulatsky M, Sulatskaya A, Mikhailova E, Stepanenko O
Int J Biol Macromol
. 2024 Nov;
282(Pt 5):137412.
PMID: 39521223
The transition of β-barrel proteins from a soluble to an amyloid form is biologically significant in some cases but may lead to functional activity loss. In particular, odorant-binding proteins' (OBPs)...
4.
Stepanenko O, Sulatsky M, Mikhailova E, Stepanenko O, Sulatskaya A
Int J Biol Macromol
. 2024 Oct;
281(Pt 3):136362.
PMID: 39395518
Over the past decade, the greatest promise for treating severe and currently incurable systemic and neurodegenerative diseases has turned to agents capable of effectively degrading pathological amyloid deposits without causing...
5.
Stepanenko O, Sulatsky M, Mikhailova E, Stepanenko O, Kuznetsova I, Turoverov K, et al.
Int J Mol Sci
. 2024 Jun;
25(12).
PMID: 38928518
In the original [...].
6.
Sulatsky M, Stepanenko O, Stepanenko O, Povarova O, Kuznetsova I, Turoverov K, et al.
J Adv Res
. 2024 Apr;
PMID: 38642804
Background: The accumulation of ordered protein aggregates, amyloid fibrils, accompanies various neurodegenerative diseases (such as Parkinson's, Huntington's, Alzheimer's, etc.) and causes a wide range of systemic and local amyloidoses (such...
7.
Sulatskaya A, Stepanenko O, Sulatsky M, Mikhailova E, Kuznetsova I, Turoverov K, et al.
Int J Biol Macromol
. 2024 Mar;
264(Pt 2):130699.
PMID: 38460650
The formation of amyloid fibrils is associated with many severe pathologies as well as the execution of essential physiological functions by proteins. Despite the diversity, all amyloids share a similar...
8.
Sulatsky M, Stepanenko O, Stepanenko O, Kuznetsova I, Turoverov K, Sulatskaya A
Anal Chem
. 2024 Jan;
96(5):2158-2164.
PMID: 38269442
Ordered protein aggregates, amyloid fibrils, form toxic plaques in the human body in amyloidosis and neurodegenerative diseases and provide adaptive benefits to pathogens and to reduce the nutritional value of...
9.
Stepanenko O, Sulatskaya A, Sulatsky M, Mikhailova E, Kuznetsova I, Turoverov K, et al.
Int J Biol Macromol
. 2023 Sep;
253(Pt 3):126872.
PMID: 37722633
Odorant-binding proteins are involved in perceiving smell by capturing odorants within the protein's β-barrel. On the example of bovine odorant-binding protein (bOBP), the structural organization of such proteins and their...
10.
Sulatsky M, Stepanenko O, Stepanenko O, Mikhailova E, Kuznetsova I, Turoverov K, et al.
Front Mol Biosci
. 2023 Jun;
10:1208059.
PMID: 37377863
The most obvious manifestation of amyloidoses is the accumulation of amyloid fibrils as plaques in tissues and organs, which always leads to a noticeable deterioration in the patients' condition and...